開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
NZD/USD up 0.5% intraday at 0.5825.
2026-09-11
NZD/USD up 0.5% intraday at 0.5825.
返回
其他消息
2026-09-11
Sept. 11 — China’s National Healthcare Security Administration organized a morning expert meeting on surgical robots with representatives from seven domestic and foreign manufacturers, including MicroPort, Medtronic, Intuitive‑Fosun, Stryker, Huake Precision, Shenzhen Jingfeng and Beijing Tianzhihang, and delegations from Guangdong Provincial People’s Hospital, Peking University People’s Hospital, Beijing Tiantan Hospital, Jishuitan Hospital and Beijing Tongren Hospital. Participants broadly agr
Sept. 11 — China’s National Healthcare Security Administration organized a morning expert meeting on surgical robots with representatives from seven domestic and foreign manufacturers, including MicroPort, Medtronic, Intuitive‑Fosun, Stryker, Huake Precision, Shenzhen Jingfeng and Beijing Tianzhihang, and delegations from Guangdong Provincial People’s Hospital, Peking University People’s Hospital, Beijing Tiantan Hospital, Jishuitan Hospital and Beijing Tongren Hospital. Participants broadly agreed that surgical-robot functions should be expanded beyond high-concentration areas (urology, orthopedics, general surgery) into targeted applications such as neurosurgery and interventional specialties; that development should be closely integrated with fast‑advancing brain‑computer interface technology, intelligent robots and AI; and that adoption should draw on other robotics best practices, broaden clinical use cases and proceed toward partial or full autonomy with cautious, evidence‑based steps.
2026-09-10
The SFC has instructed HKEX under Rule 8(1) of the Securities and Futures (Stock Market Listing) Rules to suspend trading in Bokang Shiyun Pharmaceutical-B (02592.HK) from 09:00 on Sept 10, 2026. The regulator said it is seriously concerned the company’s IPO may have been artificially manipulated to create false demand and considers the suspension necessary while it investigates to preserve an orderly, fair market and protect investors. The investigation is ongoing and the SFC will not comment f
The SFC has instructed HKEX under Rule 8(1) of the Securities and Futures (Stock Market Listing) Rules to suspend trading in Bokang Shiyun Pharmaceutical-B (02592.HK) from 09:00 on Sept 10, 2026. The regulator said it is seriously concerned the company’s IPO may have been artificially manipulated to create false demand and considers the suspension necessary while it investigates to preserve an orderly, fair market and protect investors. The investigation is ongoing and the SFC will not comment further.
Chat with us
, powered by
LiveChat